Public Data
8 samples
N6-methyladenosine modification is essential for prostate cancer cells
Accession: SRP347511
Published: 2023 in Mol Cell
cell line
control, crispr
prostate gland
prostate cancer
Public Data
123 samples
Profiling transcriptomic responses of human stem cell-derived medium spiny neuron-like cells to exogenous phasic and tonic neurotransmitters
Accession: SRP447848
Published: 2023 in Mol Cell Neurosci
cell line
compound, control
blood, pleural effusion
blast phase chronic myelogenous leukemia, BCR-ABL1 positive, ...
Public Data
15 samples
Zwitterionic Microgel Preservation Platform for Circulating Tumor Cells in Whole Blood Specimen
Accession: SRP448204
Published: 2023
primary tissue
control, other
breast
breast cancer
Public Data
24 samples
RNA-seq of AML cells in control and abemaciclib-treated groups.
Accession: SRP333815
Published: 2023
cell line
compound, control
blood, bone marrow
acute myeloid leukemia
Public Data
32 samples
Differentiation of iPSCs into Hematopoietic Stem and Progenitor Cells (HSPCs) across human, chimpanzee, and pig-tailed macaque
Accession: SRP448192
Published: 2023
cell line, primary cells
Public Data
24 samples
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells [TT-Seq]
Accession: SRP385710
Published: 2023
cell line
compound
acute myeloid leukemia
Public Data
24 samples
Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (orig)
Accession: SRP397516
Published: 2023 in Cancer Res
cell line
compound, compound, ...
breast
breast cancer
Public Data
30 samples
Endocrine treatment potentiates antigen presentation and in combination with SMAC mimetics enhances an anti-tumor immune response in hormone receptor positive breast cancer (RNA-seq)
Accession: SRP397510
Published: 2023 in Cancer Res
cell line
compound, compound, ...
breast
breast cancer
Public Data
54 samples
GDF15 gene suppression by BET inhibition and gene signature based personalized chemotherapy to counteract cachexia [Quant-seq]
Accession: SRP389959
Published: 2023 in Sci Rep
cell line
compound, control
colon
colon carcinoma
Public Data
34 samples
GDF15 gene suppression by BET inhibition and gene signature based personalized chemotherapy to counteract cachexia [RNA-seq]
Accession: SRP389957
Published: 2023 in Sci Rep
cell line
compound, control
lung
small cell lung carcinoma
Public Data
9 samples
Repression of ARNT2 Maintains Stemness and Limits Differentiation of Glioblastoma Cells
Accession: SRP447565
Published: 2023
cell line
control, crispr
brain
glioblastoma
Public Data
6 samples
Tripartite motif 8 promotes hepatocellular carcinogenesis by mediating ubiquitination and degradation of hepatocyte nuclear factor 1a
Accession: SRP447099
Published: 2023 in Cell Death Dis
cell line
control, crispr
liver
hepatocellular carcinoma
Public Data
249 samples
Restoring Tumor Immunogenicity with Dendritic Cell Reprogramming [human RNA-Seq]
Accession: SRP367505
Published: 2023 in Sci Immunol
cell line, primary cells
control, overexpression
bile duct, blood, ...
bile duct carcinoma, breast adenocarcinoma, ...
Public Data
12 samples
Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism
Accession: SRP272079
Published: 2023 in Oncogene
cell line
control, shrna
pancreas
pancreatic ductal adenocarcinoma
Public Data
10 samples
The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
Accession: SRP350678
Published: 2023 in Cancer Lett
cell line
compound, control
breast
breast cancer